May 27, 2014
Product Manager Akihiro Mitamura Taisho Toyama Pharmaceutical aims to grow the sodium-glucose co-transporter-2 (SGLT-2) inhibitor Lusefi (luseogliflozin) as a long-term bestseller by prioritizing safety during detailing activities, the company said in a recent interview with Jiho. Akihiro Mitamura, Lusefi product...read more